1. Home
  2. LNKB vs ABSI Comparison

LNKB vs ABSI Comparison

Compare LNKB & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKB
  • ABSI
  • Stock Information
  • Founded
  • LNKB 2018
  • ABSI 2011
  • Country
  • LNKB United States
  • ABSI United States
  • Employees
  • LNKB N/A
  • ABSI N/A
  • Industry
  • LNKB
  • ABSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNKB
  • ABSI Health Care
  • Exchange
  • LNKB Nasdaq
  • ABSI Nasdaq
  • Market Cap
  • LNKB 284.4M
  • ABSI 318.2M
  • IPO Year
  • LNKB N/A
  • ABSI 2021
  • Fundamental
  • Price
  • LNKB $7.28
  • ABSI $2.90
  • Analyst Decision
  • LNKB Hold
  • ABSI Strong Buy
  • Analyst Count
  • LNKB 1
  • ABSI 6
  • Target Price
  • LNKB $7.50
  • ABSI $8.50
  • AVG Volume (30 Days)
  • LNKB 70.7K
  • ABSI 5.8M
  • Earning Date
  • LNKB 01-27-2025
  • ABSI 11-12-2024
  • Dividend Yield
  • LNKB 4.12%
  • ABSI N/A
  • EPS Growth
  • LNKB 61.51
  • ABSI N/A
  • EPS
  • LNKB 0.17
  • ABSI N/A
  • Revenue
  • LNKB $86,138,000.00
  • ABSI $4,207,000.00
  • Revenue This Year
  • LNKB N/A
  • ABSI $8.57
  • Revenue Next Year
  • LNKB $9.23
  • ABSI $169.72
  • P/E Ratio
  • LNKB $43.36
  • ABSI N/A
  • Revenue Growth
  • LNKB 151.51
  • ABSI N/A
  • 52 Week Low
  • LNKB $5.86
  • ABSI $2.45
  • 52 Week High
  • LNKB $7.98
  • ABSI $6.72
  • Technical
  • Relative Strength Index (RSI)
  • LNKB 46.29
  • ABSI 46.98
  • Support Level
  • LNKB $7.04
  • ABSI $2.66
  • Resistance Level
  • LNKB $7.57
  • ABSI $2.97
  • Average True Range (ATR)
  • LNKB 0.17
  • ABSI 0.34
  • MACD
  • LNKB -0.03
  • ABSI -0.00
  • Stochastic Oscillator
  • LNKB 46.99
  • ABSI 21.19

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: